US 12,138,265 B2
Heteroaryl compounds, pharmaceutical compositions thereof, and their therapeutic use
Irit Snir-Alkalay, Mevasseret Zion (IL); Joseph P. Vacca, Telford, PA (US); and Yinon Ben-Neriah, Mevasseret Zion (IL)
Assigned to Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Jerusalem (IL)
Filed by Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Jerusalem (IL)
Filed on Jan. 25, 2023, as Appl. No. 18/159,176.
Application 18/159,176 is a continuation of application No. 16/968,273, abandoned, previously published as PCT/IL2019/050151, filed on Feb. 7, 2019.
Claims priority of provisional application 62/627,921, filed on Feb. 8, 2018.
Claims priority of provisional application 62/627,908, filed on Feb. 8, 2018.
Prior Publication US 2023/0233562 A1, Jul. 27, 2023
Int. Cl. C07D 403/04 (2006.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01); C07D 405/14 (2006.01); C07D 413/04 (2006.01); C07D 495/04 (2006.01)
CPC A61K 31/506 (2013.01) [A61P 35/00 (2018.01); C07D 403/04 (2013.01); C07D 405/14 (2013.01); C07D 413/04 (2013.01); C07D 495/04 (2013.01)] 3 Claims
 
1. A compound selected from:

OG Complex Work Unit Chemistry